Keywords: مانع بازرسی ایمن; Head and neck cancer; PD-1; Immune checkpoint blockade;
مقالات ISI مانع بازرسی ایمن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مانع بازرسی ایمن; Breast cancer; Immunotherapy; Cancer vaccine; Immune checkpoint blockade; Adoptive cell transfer; Chemotherapy; Radiotherapy;
Keywords: مانع بازرسی ایمن; HPV; human papilloma virus; CC; cervical cancer; EC; endometrial cancer; CIN; cervical intraepithelial neoplasia; VIN; vulvar intraepithelial neoplasia; VaIN; vaginal intraepithelial neoplasia; CTLA-4; cytotoxic T-lymphocyte-associated antigen 4; PD-1; pr
Keywords: مانع بازرسی ایمن; VEGF; vascular endothelial growth factor; TNF-α; tumor-necrosis-factor a; PDGFB; platelet-derived growth factor B; PIGF; placental growth factor; Sema3A; Semaphorin3A; TAM; Tumor-associated macrophages; TEM; Tie2-expressing macrophages; TAN; Tumor-associ
Keywords: مانع بازرسی ایمن; immune checkpoint blockade; ipilimumab; nivolumab; squamous cell carcinoma; cSCC; cutaneous squamous cell carcinoma; DICB; dual immune checkpoint blockade; ICB; immune checkpoint blockade; ipi/nivo; ipilimumab and nivolumab; mcSCC; metastatic cSCC;
Keywords: مانع بازرسی ایمن; Systems immunology; Immune repertoire sequencing; Adoptive cell therapy; Immune checkpoint blockade; Immune engineering;
Keywords: مانع بازرسی ایمن; Mucosal melanoma; Prognosis; Immune checkpoint blockade; Targeted therapy; KIT; Staging; Survival;
Keywords: مانع بازرسی ایمن; TME; tumour microenvironment; PD-1; programmed cell death 1; PD-L1; programmed death ligand 1; PD-L2; programmed death ligand 2; PTMs; post-translational histone modifications; DNMTi; DNA methyltransferase inhibitor; HDACi; histone deacetylase inhibitor;
Keywords: مانع بازرسی ایمن; Immune-related adverse events; Immune checkpoint blockade; Cytotoxic T-lymphocyte-associated antigen 4; Anti-PD-1 antibody; Tumour neoantigen;
Keywords: مانع بازرسی ایمن; Urothelial carcinoma; Bladder cancer; Immunotherapy; Immune checkpoint blockade; PD-1; CTLA-4; Oncolytic virus;
Keywords: مانع بازرسی ایمن; Colorectal cancer; Targeted therapy; Lynch syndrome; Microsatellite instability; Mismatch repair; EGFR pathway; Immune checkpoint blockade; PD-L1
Keywords: مانع بازرسی ایمن; Immunotherapy; NSCLC; Immune checkpoint blockade; CTLA-4; PD-1; PD-L1
Keywords: مانع بازرسی ایمن; Breast cancer; Immune system; Biomarkers; Immunotherapies; Immune checkpoint blockade; Tumor vaccines; ADCC; antibody dependent cellular cytotoxicity; BiTES; bispecific single chain monoclonal antibodies; CAR; T cells engineered to express artificial chim
Positive Pelvic Lymph Nodes in Prostate Cancer Harbor Immune Suppressor Cells To Impair Tumor-reactive T Cells
Keywords: مانع بازرسی ایمن; Prostate cancer; Immune checkpoint blockade; Salvage lymphadenectomy; Immuno-oncology;
HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers
Keywords: مانع بازرسی ایمن; Human immunodeficiency virus; Human Papillomavirus; Head and neck cancer; PD-1; PD-L1; Immune checkpoint blockade; Antigen processing machinery;
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
Keywords: مانع بازرسی ایمن; Cancer immunotherapy; Immune checkpoint blockade; CTLA-4; PD-1; PD-L1;
TGFβ pathway inhibition in the treatment of non-small cell lung cancer
Keywords: مانع بازرسی ایمن; ALK; Anaplastic leukemia kinase; CAF; Cancer-associated fibroblast; EGFR; Epidermal growth factor receptor; EMT; Epithelial-to-mesenchymal transition; MSC; Mesenchymal stem cell; NK Cell; Natural killer cell; NSCLC; Non-small cell lung cancer; OS; Overall
Immunothérapie des tumeurs cérébrales
Keywords: مانع بازرسی ایمن; Tumeur cérébrale; Glioblastome; Gliome diffus; Immunothérapie; Vaccin tumoral; Blocage des points de contrôle immunitaires; Transfert adoptif de lymphocytes T; Brain tumor; Glioblastoma; Diffuse glioma; Immunotherapy; Tumor vaccine; Immune checkpoint
Original ResearchPrognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition
Keywords: مانع بازرسی ایمن; Ipilimumab; Pembrolizumab; Nivolumab; Immune checkpoint blockade; Uveal melanoma; Biomarker;
Original ResearchThe proportion of circulating CD45RO+CD8+ memory T cells is correlated with clinical response in melanoma patients treated with ipilimumab
Keywords: مانع بازرسی ایمن; Melanoma; Immune checkpoint blockade; Ipilimumab; Pembrolizumab; CD45RO+CD8+ T cells; Predictive marker; HLA-DR+CD25âCD8+ phenotype;
ReviewCancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
Keywords: مانع بازرسی ایمن; Tumour immunity; Cancer immunotherapy; Immune checkpoint blockade; Cytotoxic T lymphocyte antigen-4 (CTLA-4); Programmed death-1 (PD-1); Programmed death ligand-1 (PD-L1);
FAP positive fibroblasts induce immune checkpoint blockade resistance in colorectal cancer via promoting immunosuppression
Keywords: مانع بازرسی ایمن; Colorectal cancer; Cancer-associated fibroblast; Fibroblast activation protein-alpha; Immune checkpoint blockade; CCL2;
Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review
Keywords: مانع بازرسی ایمن; Uveal melanoma; CTLA-4; Ipilimumab; Immune checkpoint blockade; Pembrolizumab; Nivolumab;
Combining targeted therapy with immunotherapy. Can 1Â +Â 1 equal more than 2?
Keywords: مانع بازرسی ایمن; Targeted therapy; Immune checkpoint blockade; Adoptive cell transfer; Combination therapy;
Association of PDCD1 and CTLA-4 Gene Expression with Clinicopathological Factors and Survival in Non-Small-Cell Lung Cancer: Results from a Large and Pooled Microarray Database
Keywords: مانع بازرسی ایمن; Non-small-cell lung cancer; Immune checkpoint blockade; PDCD1; CTLA-4; Smoking; Squamous carcinoma; Adenocarcinoma; Prognosis; Microarray;
TLR3 triggering regulates PD-L1 (CD274) expression in human neuroblastoma cells
Keywords: مانع بازرسی ایمن; Neuroblastoma; Immune therapy; PD-1/PD-L1; Immune checkpoint blockade; TLR ligands in cancer therapy; Therapeutic antibodies
PD-1 and PD-L1 blockade in gastrointestinal malignancies
Keywords: مانع بازرسی ایمن; Programmed death; PD-1; PD-L1; Gastrointestinal cancer; Immunotherapy; Immune checkpoint blockade;